Loading...
TP53 mutational status is predictive of pazopanib response in advanced sarcomas
BACKGROUND: To investigate whether TP53 DNA mutational status impacts progression-free survival (PFS) in patients with advanced sarcomas (soft tissue sarcoma) treated with vascular endothelial growth factor receptors (VEGFR) inhibition. PATIENTS AND METHODS: We retrospectively reviewed 19 cases of p...
Saved in:
| Published in: | Ann Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5006122/ https://ncbi.nlm.nih.gov/pubmed/26646755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdv598 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|